Mera Pharmaceuticals, Inc. (MRPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 25, 2026
Mera Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2011 | FY 2010 | FY 2009 | 2008 - 2004 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '21 Jul 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 | Oct '11 Oct 31, 2011 | Oct '10 Oct 31, 2010 | Oct '09 Oct 31, 2009 | 2008 - 2004 |
| Revenue | - | - | - | 0.3 | 0.29 | 0.6 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 4.75% | -51.78% | -1.79% | Upgrade
|
| Cost of Revenue | - | - | - | 0.02 | 0.05 | 0.03 | Upgrade
|
| Gross Profit | - | - | - | 0.29 | 0.24 | 0.57 | Upgrade
|
| Selling, General & Admin | 0.01 | 0.01 | 0.01 | 0.31 | 0.19 | 0.36 | Upgrade
|
| Research & Development | - | - | - | 0.17 | 0.27 | 0.32 | Upgrade
|
| Operating Expenses | 0.01 | 0.01 | 0.01 | 0.49 | 0.48 | 0.77 | Upgrade
|
| Operating Income | -0.01 | -0.01 | -0.01 | -0.2 | -0.24 | -0.2 | Upgrade
|
| Interest Expense | - | - | - | -0.01 | -0 | -0.01 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0 | -0 | - | Upgrade
|
| EBT Excluding Unusual Items | -0.01 | -0.01 | -0.01 | -0.2 | -0.24 | -0.2 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.31 | -0.02 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0 | Upgrade
|
| Pretax Income | -0.01 | -0.01 | -0.01 | -0.2 | -0.56 | -0.22 | Upgrade
|
| Income Tax Expense | - | - | - | -0.01 | -0.02 | -0.03 | Upgrade
|
| Net Income | -0.01 | -0.01 | -0.01 | -0.19 | -0.54 | -0.19 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 0.03 | 0.03 | 0.03 | Upgrade
|
| Net Income to Common | -0.01 | -0.01 | -0.01 | -0.22 | -0.57 | -0.23 | Upgrade
|
| Shares Outstanding (Basic) | 557 | 557 | 557 | 548 | 548 | 547 | Upgrade
|
| Shares Outstanding (Diluted) | 557 | 557 | 557 | 548 | 548 | 547 | Upgrade
|
| Shares Change (YoY) | 1.83% | - | 1.74% | - | 0.09% | 5.89% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | - | - | - | -0.07 | -0.14 | -0.05 | Upgrade
|
| Gross Margin | - | - | - | 94.63% | 84.05% | 95.32% | Upgrade
|
| Operating Margin | - | - | - | -66.44% | -82.14% | -33.69% | Upgrade
|
| Profit Margin | - | - | - | -72.90% | -197.58% | -37.69% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -24.49% | -48.96% | -8.44% | Upgrade
|
| EBITDA | - | - | - | -0.19 | -0.21 | -0.12 | Upgrade
|
| EBITDA Margin | - | - | - | -63.69% | -72.44% | -19.56% | Upgrade
|
| D&A For EBITDA | - | - | - | 0.01 | 0.03 | 0.08 | Upgrade
|
| EBIT | -0.01 | -0.01 | -0.01 | -0.2 | -0.24 | -0.2 | Upgrade
|
| EBIT Margin | - | - | - | -66.44% | -82.14% | -33.69% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.